Skip to main content
Fig. 2 | Health and Quality of Life Outcomes

Fig. 2

From: Vision-related quality of life in patients receiving intravitreal ranibizumab injections in routine clinical practice: baseline data from the German OCEAN study

Fig. 2

a Differences in baseline VFQ-25 scores by indication (nAMD/DME/RVO). b Differences in baseline VFQ-25 scores by age. c Baseline VFQ-25 scores by gender. d Variations in baseline VFQ-25 scores in treatment-naïve patients dependent on baseline BCVA. e Baseline VFQ-25 scores of treatment-naïve patients by health insurance type

Back to article page
\